BCM
APVO icon

Bridgeway Capital Management’s Aptevo Therapeutics APVO Stock Holding History

Bridgeway Capital Management’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Hold
0
– -$55K – 1310
2019
Q3 		– Hold
0
– – – 1271
2019
Q2 		– Hold
0
– – – 1257
2019
Q1 		– Hold
0
– – – 1290
2018
Q4 		– Hold
0
– – – 1279
2018
Q3 		– Hold
0
– – – 1155
2018
Q2 		– Hold
0
– – – 1156
2018
Q1 		– Hold
0
– – – 1199
2017
Q4 		– Hold
0
– – – 1278
2017
Q3 		– Hold
0
– – – 1337
2017
Q2 		– Hold
0
– – – 1363
2017
Q1 		– Hold
0
– – – 1356

Other funds holding APVO

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return